CJC-1295 Therapy in Miami
A long-acting GHRH analog that provides sustained growth hormone elevation — CJC-1295 extends the benefits of growth hormone optimization between doses and is most commonly prescribed alongside ipamorelin for synergistic results.
What Is CJC-1295?
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) — the natural hormone produced by the hypothalamus that signals the pituitary gland to produce and release human growth hormone (HGH). Like sermorelin, CJC-1295 works by binding to GHRH receptors on the pituitary gland to stimulate the body's own growth hormone production. However, CJC-1295 was specifically engineered to address a key limitation of natural GHRH and first-generation analogs: their extremely short half-life.
Natural GHRH and sermorelin are cleared from the bloodstream within minutes, producing a brief pulse of growth hormone release. CJC-1295 was modified to resist enzymatic degradation, giving it a dramatically longer half-life that sustains growth hormone elevation for hours to days depending on the formulation.
How CJC-1295 Works
Engineered for sustained growth hormone elevation — CJC-1295 continues stimulating the pituitary for a prolonged period, creating a more consistent hormonal environment.
GHRH Receptor Binding
CJC-1295 binds to GHRH receptors on somatotroph cells in the anterior pituitary, stimulating the synthesis and release of growth hormone.
Sustained Duration
Engineered to resist enzymatic degradation, providing elevated GH and IGF-1 levels that persist for hours to days depending on the formulation.
Feedback Preserved
Works through the pituitary gland, keeping your body's natural somatostatin feedback mechanisms intact. Optimization — not override.
IGF-1 Elevation
Increased HGH stimulates the liver to produce IGF-1, the downstream mediator responsible for many of growth hormone's tissue-level effects.
How peptide therapy powered Audrey's remarkable results.
Step-by-step reconstitution guidance from our clinical team.
With DAC vs. Without DAC
CJC-1295 is available in two distinct formulations. Understanding the difference is important for choosing the right protocol.
| Feature | CJC-1295 with DAC | CJC-1295 without DAC (Mod GRF 1-29) |
|---|---|---|
| Half-life | 6-8 days | ~30 minutes |
| GH pattern | Sustained, continuous elevation | Pulsatile, burst-like release |
| Dosing frequency | 1-2 times per week | Daily (typically before bed) |
| Best for | Steady GH elevation, less frequent injections | Pairing with ipamorelin, pulsatile pattern |
| Albumin binding | Yes — extends duration | No |
CJC-1295 with DAC
The DAC modification allows CJC-1295 to bind to serum albumin, extending its half-life to approximately 6 to 8 days. The result is sustained, continuous elevation of growth hormone and IGF-1 levels. Ideal for patients who prefer less frequent injections and want consistent GH elevation throughout the week.
CJC-1295 without DAC (Mod GRF 1-29)
Without the DAC modification, CJC-1295 has a shorter half-life of approximately 30 minutes, producing a more pulsatile release pattern closer to how your body naturally releases GH in bursts during sleep. This is the formulation most commonly combined with ipamorelin.
Benefits of CJC-1295 Therapy
By sustaining elevated growth hormone and IGF-1 levels, CJC-1295 produces a broad range of benefits that address multiple aspects of age-related decline.
Increased Lean Muscle Mass
Sustained GH elevation drives protein synthesis and muscle cell proliferation. Patients report improved muscle tone, faster strength gains, and better recovery between workouts.
Improved Bone Density
Optimizing growth hormone stimulates osteoblast activity, calcium retention, and bone mineralization — critical for patients over 40 at risk of osteopenia.
Fat Loss & Metabolic Improvement
Sustained GH elevation keeps the body in a fat-burning metabolic state more consistently. Patients see reductions in visceral fat and improved metabolic markers over 3-6 months.
Enhanced Recovery
Sustained GH action means tissue repair benefits are present around the clock — not just in the hours after injection. Especially valued by athletes and active adults.
Sleep Quality
Enhanced GH production improves deep, slow-wave sleep. Often the first benefit patients notice — typically within one to two weeks.
Skin & Connective Tissue
Stimulates collagen synthesis and connective tissue repair. Patients report improved skin elasticity, reduced fine lines, and better hydration over 3-6 months.
CJC-1295 + Ipamorelin: The Gold Standard
The combination of CJC-1295 with ipamorelin is the most prescribed growth hormone peptide protocol in anti-aging medicine. These two peptides stimulate growth hormone release through two independent receptor pathways:
- CJC-1295 activates GHRH receptors — the same pathway used by your body's natural growth hormone-releasing hormone
- Ipamorelin activates ghrelin receptors (GHS-R) — an entirely separate signaling pathway on the pituitary
Stimulating both pathways simultaneously produces a synergistic growth hormone response — the combined GH output is significantly greater than the sum of each peptide individually. Additionally, ipamorelin's exceptional selectivity means the combination retains a clean side effect profile.
The Rewind Protocol
Consultation & Blood Work
Baseline labs including IGF-1, comprehensive metabolic panel, and relevant markers. We confirm GH peptide therapy is appropriate for you.
Formulation Selection
We select the right formulation — with or without DAC — based on your goals, lifestyle, and whether we're combining with ipamorelin.
Protocol Design
Personalized dosing, injection schedule, and combination strategy. CJC-1295 + ipamorelin is our most popular protocol.
Follow-Up & Optimization
Labs at 8-12 weeks to assess IGF-1 response. Dosing adjusted based on results, symptoms, and how you feel.
Side Effects
CJC-1295 is generally well tolerated with a favorable safety profile. Commonly reported side effects are mild and typically transient.
- Injection site reactions — Mild redness, irritation, or tenderness. Most common, typically resolving quickly.
- Water retention — Temporary fluid retention during initial weeks, more common with the DAC formulation. Usually normalizes.
- Tingling or numbness — Occasional tingling in hands or feet, related to increased GH activity. Mild and responsive to dose adjustment.
- Headache — Infrequent and usually limited to the initial treatment period.
- Flushing — Temporary warmth or flushing shortly after injection, usually brief.
We monitor IGF-1 levels at follow-up appointments to ensure you remain within the optimal range.
CJC-1295 Therapy at Rewind Anti-Aging of Miami
Every CJC-1295 protocol begins with a consultation and baseline blood work — including IGF-1, comprehensive metabolic panel, and other relevant markers. We use these results to confirm that growth hormone peptide therapy is appropriate for you, select the right formulation (with or without DAC), and establish your baseline for tracking progress.
Follow-up labs at 8 to 12 weeks assess your IGF-1 response, and we adjust dosing based on your lab results, symptom improvement, and how you feel. CJC-1295 integrates with our broader optimization services — testosterone therapy, weight management, and comprehensive peptide therapy — for patients building a complete anti-aging protocol. Many patients ask whether CJC-1295 increases testosterone — read our blog post for what the research shows.
Related Treatments
Ipamorelin Therapy
A selective growth hormone secretagogue often paired with CJC-1295 for synergistic GH release.
Learn more →Sermorelin Therapy
Growth hormone-releasing peptide that stimulates your pituitary gland to naturally increase HGH production.
Learn more →Tesamorelin Therapy
FDA-approved GHRH analog that targets visceral fat reduction while boosting growth hormone levels.
Learn more →Explore CJC-1295 in Depth
Does CJC-1295 Increase Testosterone?
What the research says about CJC-1295 and testosterone levels.
Sermorelin vs CJC-1295: Comparing Growth Hormone Peptides
How these two GHRH analogs differ in mechanism and clinical use.
What Is Peptide Therapy?
An overview of peptide therapy and how it supports healthy aging.
Frequently Asked Questions About CJC-1295
What is the difference between CJC-1295 with DAC and without DAC?
DAC stands for Drug Affinity Complex — a chemical modification that allows CJC-1295 to bind to albumin in the bloodstream, dramatically extending its half-life from minutes to approximately 6-8 days. CJC-1295 with DAC provides sustained, continuous GH elevation and is typically dosed once or twice per week. CJC-1295 without DAC (sometimes called modified GRF 1-29) has a shorter half-life of about 30 minutes and produces a more pulsatile GH release pattern, dosed daily. Your provider will recommend the formulation that best fits your protocol.
How is CJC-1295 different from sermorelin?
Both CJC-1295 and sermorelin are GHRH analogs that stimulate the pituitary gland to produce growth hormone through the same receptor type. The primary difference is half-life. Sermorelin is active for only a few minutes after injection, while CJC-1295 (especially with DAC) remains active for days. This longer duration of action produces more sustained GH and IGF-1 elevation between doses. Sermorelin produces a sharper, more pulsatile GH spike, while CJC-1295 provides steadier baseline elevation.
Why is CJC-1295 combined with ipamorelin?
CJC-1295 and ipamorelin stimulate growth hormone release through two completely different receptor pathways — GHRH receptors and ghrelin receptors, respectively. Activating both pathways simultaneously produces a synergistic GH response significantly greater than either peptide alone. This dual-pathway approach is the most commonly prescribed growth hormone peptide protocol in the anti-aging field and is our most popular peptide combination at Rewind Anti-Aging of Miami.
How long does it take to see results from CJC-1295?
Improved sleep quality is typically the first benefit patients notice, usually within the first one to two weeks. Increased energy, better recovery, and improved mood develop over the first one to two months. Body composition changes — visible fat loss, improved muscle tone, better skin quality — generally become apparent between months three and six. Full optimization of IGF-1 levels usually takes three to six months of consistent use.
What are the side effects of CJC-1295?
CJC-1295 is generally well tolerated. Common side effects are mild and include injection site reactions (redness, irritation), temporary water retention, tingling or numbness in the extremities, mild headache, and occasional flushing. These effects are typically transient and resolve as the body adjusts. The CJC-1295 with DAC formulation may cause more sustained water retention initially due to its longer duration of action.
Can I take CJC-1295 with hormone replacement therapy?
Yes. CJC-1295 and hormone replacement therapy are complementary. Testosterone or estrogen optimization addresses your sex hormone levels while CJC-1295 enhances growth hormone production — they target different aspects of age-related hormonal decline. Many patients at Rewind Anti-Aging of Miami use growth hormone peptides alongside testosterone therapy or female HRT as part of a comprehensive hormone optimization strategy.
Sustained Growth Hormone Optimization with CJC-1295
Schedule a consultation to discuss CJC-1295 therapy, get baseline labs, and build a growth hormone protocol tailored to your goals.
⚕ Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. All treatments at Rewind Anti-Aging of Miami are performed under the supervision of licensed medical professionals. Individual results may vary. Consult your physician before beginning any new treatment protocol.
Meet our clinical team →Areas We Serve in Miami & South Florida
Our Wynwood clinic at 24 NW 29th Street serves patients across the Miami metro in person and the entire state of Florida via telehealth.